Cargando…

Photodynamic therapy of laryngeal cancers

Detalles Bibliográficos
Autor principal:	Biel, Merrill
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007698/ http://dx.doi.org/10.1186/1758-3284-2-S1-O25

Ejemplares similares

Treatment planning for Interstitial Photodynamic Therapy for head and neck cancer
por: van Veen, RLP, et al.
Publicado: (2010)

The role of photodynamic therapy in the management of oral dysplasia
por: Hopper, Colin, et al.
Publicado: (2010)

Photodynamic therapy as the "last hope" for tongue-based carcinoma
por: Jerjes, Waseem, et al.
Publicado: (2010)

Ultrasound-guided interstitial photodynamic therapy for deeply seated pathologies: assessment of outcome
por: Osher, Jonas, et al.
Publicado: (2010)

In vivo monitoring of Foscan-mediated photodynamic therapy in clinical head and neck procedures using optical spectroscopy
por: Kanick, Stephen, et al.
Publicado: (2010)

Utilizing 5-aminolevulinic acid and pulsed dye laser for photodynamic therapy of oral leukoplakia – pilot study
por: Shafirstein, Gal, et al.
Publicado: (2010)

P268 Laryngeal Mucormycosis: does mucor take the voice away?
por: Rege, Sujata, et al.
Publicado: (2022)

Laryngeal Tube as airway rescue device from prehospital to tracheostomy: case report
por: Giugni, Aimone, et al.
Publicado: (2009)

Automatic segmentation of clinical OCT images for the determination of epithelial thickness changes in laryngeal lesions
por: Wisweh, Henning, et al.
Publicado: (2010)

Physiological roles of cGMP-gated channels: lessons from mouse models and human channelopathies
por: Biel, Martin, et al.
Publicado: (2009)

Effects of methylene blue photodynamic therapy on oral carcinoma and leukoplakia cells
por: Le, Mina N., et al.
Publicado: (2022)

Monoclonal antibodies for the therapy of cancer
por: Simpson, Andrew, et al.
Publicado: (2014)

Locoregional therapy of renal cancer
por: Wah, Tze Min
Publicado: (2014)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

Cancer therapy by resuscitating Notch immune surveillance
por: Shanker, Anil, et al.
Publicado: (2014)

PSMA ligands for diagnosis and therapy of prostate cancer
por: Haberkorn, Uwe
Publicado: (2014)

Complications following locoregional therapy of renal cancer
por: Krokidis, Miltiadis
Publicado: (2014)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Adjuvant therapy in colorectal cancer – studies of the FOGT group
por: Staib, Ludger, et al.
Publicado: (2010)

The EGF receptor family as targets for breast cancer therapy
por: Baselga, J
Publicado: (2000)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Targeting the cell cycle for prognosis and therapy of breast cancer
por: Keyomarsi, K, et al.
Publicado: (2005)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

Biguanide therapy for diabetes and cancer & a novel methyltransferase that regulates energy expenditure and adiposity and is elevated in many cancers
por: Kahn, Barbara B, et al.
Publicado: (2014)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
por: Nowicki, PW, et al.
Publicado: (2009)

Modulating immunometabolism of tumor specific CD8 T cells to enhance T cell based therapy for cancer
por: Sukumar, Madhusudhanan, et al.
Publicado: (2014)

16. Checking in with novel cancer therapies: a case of immunotherapy-related large vessel vasculitis
por: Man, Yik Long, et al.
Publicado: (2019)

Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies
por: Al-Khami, Amir A, et al.
Publicado: (2015)

Cell therapies for joint repair
por: De Bari, Cosimo
Publicado: (2015)

Colchicine therapy in children with FMF
por: Knieper, A-M, et al.
Publicado: (2015)

Cancer occurrence during follow-up of the CAPP2 study -aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to several years after completion of therapy
por: Burn, John, et al.
Publicado: (2010)

Mitochondrial ageing and antiretroviral therapy exposure
por: Payne, BAI, et al.
Publicado: (2010)

Secretases: potential and roadblocks on the way to therapy
por: De Strooper, Bart
Publicado: (2013)

Cavitation detection for brain imaging and therapy
por: O’Reilly, Meaghan, et al.
Publicado: (2015)

Preoperative hormonal therapy: results and implications
por: Dowsett, M
Publicado: (2005)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Update on HER2-directed therapy
por: Slamon, D
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_3t6fk90go226a8lrrqfb951s1a